3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Psoriasis
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Paget's Disease, Mammary
1
Osteoarthritis
1
Obesity
1
Neoplasms
1
Neoplasm, Residual
1
Fatigue
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Cachexia
1
Breast Carcinoma In Situ
1
Barrett Esophagus
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Aggressive Periodontitis
1
Interventions
aldesleukin
15
Cyclophosphamide
15
fludarabine phosphate
12
fludarabine
11
Interleukin-2
10
Nivolumab
6
Ipilimumab
6
Temozolomide
5
pembrolizumab
3
Fluorouracil
3
trametinib
2
sonidegib
2
dabrafenib
2
binimetinib
2
Whole-Body Irradiation
2
Vemurafenib
2
Tacrolimus
2
Sodium Chloride
2
Sirolimus
2
Radiotherapy
2
Radiation
2
Peptides
2
HhAntag691
2
Gefitinib
2
Dacarbazine
2
Cyclosporine
2
Cetuximab
2
Capecitabine
2
veliparib
1
varlilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Skin Neoplasms
×
Docosahexaenoic Acids
×
Clear all
No trials found.